Nitrostat and Rapamune drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nitrostat (nitroglycerin) and Rapamune (sirolimus). Common drug interactions include immunosuppressant drug level increased among females and pneumonia among males.
The phase IV clinical study analyzes what interactions people have when they take Nitrostat and Rapamune. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Nitrostat?
Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.
What is Rapamune?
Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Nitrostat and Rapamune together, and have interactions are studied.

What are the common drug interactions of Nitrostat and Rapamune, by gender? *:
female:
- Immunosuppressant drug level increased
- Abdominal discomfort
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Bone loss
- Hearing impaired
- Renal hypertrophy (over growth of kidney)
- Blood potassium decreased
- Eye haemorrhage (bleeding in the eye)
- Fall
- Hyperlipidaemia (presence of excess lipids in the blood)
male:
- Pneumonia
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Blood creatine phosphokinase mb increased
- Blood glucose fluctuation
- Blood phosphorus decreased
- Bone disorder
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cataract (clouding of the lens inside the eye)
- Cellulitis (infection under the skin)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
What are the common drug interactions of Nitrostat and Rapamune, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Diarrhoea
- Abdominal discomfort
- Influenza
- Eye haemorrhage (bleeding in the eye)
- Vision blurred
- Anaemia (lack of blood)
- Ascites (accumulation of fluid in the abdominal cavity)
- Cardiac failure congestive
- Cardiomyopathy (weakening of the heart muscle)
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
50-59:
- Aphthous stomatitis (mouth ulcer)
- Arteriosclerosis (thickening and hardening of arteries)
- Asthma
- Back pain
- Blood creatine phosphokinase increased
- Blood creatine phosphokinase mb increased
- Blood glucose fluctuation
- Blood phosphorus decreased
- Bone disorder
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
60+:
- Pneumonia
- Blood cholesterol increased
- Herpes zoster
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
- Pulmonary oedema (fluid accumulation in the lungs)
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
- Blood potassium decreased
- Fall
- Loss of consciousness
- Swelling
What are the existing conditions these people have? *
- High Blood Cholesterol: 4 people, 17.39%
- Bone Disorder: 4 people, 17.39%
- Blood Pressure Abnormal: 4 people, 17.39%
- Blood Glucose Abnormal: 4 people, 17.39%
- Abdominal Pain Upper: 4 people, 17.39%
- Pain: 2 people, 8.70%
- High Blood Pressure: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Nitrostat and Rapamune?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Nitrostat and Rapamune:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nitrostat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rapamune:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitrostat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rapamune and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nitroglycerin and sirolimus (the active ingredients of Nitrostat and Rapamune, respectively), and Nitrostat and Rapamune (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fluphenazine cause White Blood Cell Count Increased? - 14 seconds ago
- Drug interactions of Amikacin Sulfate and Haloperidol Decanoate - 21 seconds ago
- Blood Glucose Increased and Gallbladder Disorder - 22 seconds ago
- Gabapentin and Hyperkalemia for Women aged 30-39 - 27 seconds ago
- Gabapentin and Hyperkalaemia for Women aged 30-39 - 27 seconds ago
- Gabapentin and Blood Potassium Increased for Women aged 30-39 - 27 seconds ago
- Gabapentin and Elevated Potassium for Women aged 30-39 - 27 seconds ago
- Gabapentin and Potassium - High for Women aged 30-39 - 28 seconds ago
- Gabapentin and High Potassium for Women aged 30-39 - 28 seconds ago
- Attention Deficit/Hyperactivity Disorder and drugs of ingredients of clozapine - 40 seconds ago